De-Risking a Multimillion-Dollar Platform Decision
How a global healthcare leader proved platform usability from the leadership's decision to the team running it, before committing to a multimillion-dollar platform.
A platform decision this big has to hold up at every level
Choosing a platform for incentive compensation, territory alignment, and segmentation is a call commercial operations leadership owns, and a sales ops or marketing ops team must live with. A leading healthcare organization had already run the usual process: demos, reference calls, staged reviews. Each showed what a platform could do in theory. None proved it would hold up for the people who’d use it. Recognizing this gap, the organization partnered with Axtria to design and execute a structured, hands-on validation process, with SalesIQTM as the platform under evaluation, before committing to any vendor.
What a demo never proves:
- Demos hide the manual work. Workarounds surface only after go-live, and it's the operating team that inherits them.
- Staged scenarios flatter usability. They prove nothing about whether your analysts can run the platform unaided.
- Conflicting signals go unresolved. IT and global teams reach different verdicts, and the sales or marketing ops team is left reconciling them.
Four phases that gave leadership proof and the team a dry run
Four systems were evaluated for deployment across 17 markets. SalesIQTM advanced to the proof of concept stage as the leading candidate, piloted in the two largest markets.
- Real data configuration: each platform, SalesIQTM included, ran on the client's own IC plans and hierarchies.
- Role-based user execution: IC analysts and segmentation leads ran real workflows unaided.
- Full transparency review: every workaround and hidden dependency was logged.
- Evidence-based decision: findings rolled into one scored comparison so leaders decided on evidence.
Confidence that carried through the organization
- 4 systems shortlisted; SalesIQTM advanced to a live proof of concept.
- 17 markets in scope; the two largest ran the live proof of concept.
- 4 phases systems shortlisted; SalesIQTM advanced to a live proof of concept.
- 6–12 months of typical post-rollout productivity loss avoided by day-one-ready teams.
- Complexity surfaced before go-live. Workarounds were named before any contract was signed.
- Teams ready on day one. Analysts and leads had already run real workflows in SalesIQTM.
- Business and IT aligned. Both read the same evidence.
By trading demo-driven evaluation for hands-on validation, Axtria helped this healthcare leader reach a decision that held up in the boardroom and on the ground, with SalesIQTM as the platform put to the test.
FAQs
It replaces vendor demos with client-controlled execution on real data. Skip it, and teams choose from a scripted demo only to meet the hidden workarounds after go-live, when switching is expensive.
The client validated SalesIQTM, Axtria's platform for incentive compensation, territory alignment, and segmentation, using its own data and its own users.
Sample data is chosen to flatter the platform. Real IC plans, territory hierarchies, and segmentation models reveal how it handles the client's true complexity, and whether it needs workarounds to cope.
The people who will use the platform daily (IC analysts, commercial managers, and segmentation leads) run their own workflows with little vendor help, including recalculations, realignments, segmentation, and error handling. Their firsthand experience is the clearest signal of adoption risk you can get.
Structured debriefs log every manual workaround and backend dependency, turning a vague sense of how hard a task was into a comparable number leadership can weigh.
Both groups read the same execution findings, transparency scores, and adoption-risk assessments. Agreement comes from shared evidence, so the perception gap never forms.
Yes. The four-phase model is documented as a reusable playbook, always run on the client's own data and workflows rather than vendor scenarios.
Recommended insights
Case Study